Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis

BACKGROUND: A recent phase II trial reported prolonged survival in patients with advanced biliary tract cancer (BTC) following treatment with nab-paclitaxel plus gemcitabine-cisplatin (Gem/Cis/nab-P). We aimed to evaluate the clinical outcomes of Gem/Cis/nab-P in Asian patients with advanced BTC in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheon, Jaekyung, Lee, Choong-kun, Sang, Yun Beom, Choi, Hye Jin, Kim, Min Hwan, Ji, Jun Ho, Ko, Kwang Hyun, Kwon, Chang-Il, Kim, Dae Jung, Choi, Sung Hoon, Kim, Chan, Kang, Beodeul, Chon, Hong Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358499/
https://www.ncbi.nlm.nih.gov/pubmed/34394748
http://dx.doi.org/10.1177/17588359211035983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358499/
https://www.ncbi.nlm.nih.gov/pubmed/34394748
http://dx.doi.org/10.1177/17588359211035983

Ejemplares similares